Phase 4 Hepatic Encephalopathy Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
CirrhosisAscitesPortal Vein Thrombosis+3 more
Asian Institute Of Medical Sciences220 enrolled1 locationNCT07521332
Recruiting
Phase 4
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Hepatic EncephalopathyDecompensated Cirrhosis
Post Graduate Institute of Medical Education and Research, Chandigarh336 enrolled1 locationNCT06538077
Recruiting
Phase 4
A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis
CirrhosisHepatic Encephalopathy
Asian Institute of Gastroenterology, India162 enrolled2 locationsNCT06808074
Recruiting
Phase 4
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Liver DiseasesCirrhosis, LiverPortal Hypertension+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)238 enrolled6 locationsNCT04073290